SHANGHAI, March 18 (Xinhua) — In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) a
Tag: biopharmaceuticals
Conference participants to ink host of agreements
The Belt and Road Initiative will continue to offer a viable solution for bolstering global governance and infusing robust momentum into the world\’s economic growth, China\’s top foreign trade and inve
Deals worth over 200-bln yuan inked at Smart China Expo
CHONGQING, Sept. 4 (Xinhua) — Eighty-four investment projects with contracts worth over 213.8 billion yuan (around 29.4 billion U.S. dollars) have been signed at the China Smart Expo that kicked off